Table 2 The association of PGS for lithium variants and treatment response to lithium in patients with BD at different sample splits.
Sample split | N | Categorical outcome, OR (95%CI) | Continuous outcome: ALDA total score, OR (95%CI) | ||
---|---|---|---|---|---|
ConLi+Gen | 2367 | unadjusted | adjusted | unadjusted | adjusted¥ |
80%/20% | 2083/284 | 1.31(1.19,1.43) | 1.39(1.26, 1.54) ¥ | 1.15(1.11, 1.20) | 1.17(1.13, 1.22) |
Li+PGS by decile | §R/N | ||||
First (lowest score) | 44/236 | 1[Reference] | 1[Reference]¥ | 1[Reference] | 1[Reference] |
Second | 60/237 | 1.48(0.96, 2.30) | 1.59(1.02, 2.49) | 0.94(0.79,1.12) | 0.96(0.81,1.15) |
Third | 54/237 | 1.29(0.82, 2.02) | 1.32(0.84, 2.08) | 1.07(0.90,1.28) | 1.14(0.95,1.35) |
Fourth | 70/237 | 1.83(1.19, 2.83) | 1.87(1.21, 2.91) | 1.09(0.92,1.31) | 1.14(0.96,1.36) |
Fifth | 59/236 | 1.45(0.94, 2.27) | 1.50(0.96, 2.35) | 1.12(0.93,1.34) | 1.17(0.98,1.40) |
Sixth | 62/237 | 1.55(1.00, 2.40) | 1.83(1.17, 2.87) | 1.22(1.02,1.46) | 1.31(1.09,1.55) |
Seventh | 76/237 | 2.06(1.35, 3.17) | 2.27(1.48, 3.53) | 1.15(0.96,1.38) | 1.23(1.04,1.48) |
Eighth | 68/237 | 1.76(1.14, 2.72) | 1.91(1.23, 2.99) | 1.12(0.93,1.34) | 1.17(0.98,1.39) |
Nineth | 78/237 | 2.14(1.41, 3.29) | 2.33(1.51, 3.64) | 1.45(1.21,1.72) | 1.55(1.31,1.86) |
Tenth (highest score) | 89/236 | 2.64(1.74, 4.05) | 3.47(2.22, 5.47) | 1.52(1.27,1.82) | 1.67(1.39,1.99) |